Japan is second only to the United States as a consumer of pharmaceutical products. This notwithstanding, statistical contributions to clinical trials and clinical development were not well-recognized in Japan until the ICH-E9 guideline “Statistical Principles for Clinical Trials” was implemented in 1998.
Amstat News
The Membership Magazine of the American Statistical Association